QA: RespireRx Pharmaceuticals Inc. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000849636_2018_RespireRx_Pharmaceuticals_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000849636')"}

Graph

Absolute values for 0000849636, RespireRx Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 176,711
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 18,059
4 LiabilitiesCurrent 4,550,154
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,515,846
9 ResearchAndDevelopmentExpense 1,731,565
10 remainder_Expenses 102,225
11 remainder_Revenues 0
12 remainder_NetIncome 58,153
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 194,770
1 Liabilities 4,550,154
2 Expenses 4,349,636
3 Revenues 0
4 StockholdersEquity -4,355,384
5 NetIncome -4,291,483
6 ComprehensiveNetIncome -4,291,483
7 BaseVar 4,576,356
8 EconomicCapitalRatio -4.97

Edgar->Model Mapping

Feature Distribution

Change over Time